Therapist Adherence to Cognitive-behavioral Therapy

Depression Clinical Trial

Official title:

Therapist Adherence to Evidence-based Cognitive-behavioral Therapy in a Patient Perspective

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04119258
• Other study ID #: KI-2019-04255
• Status: Completed
• Start date: November 1, 2019
• Est. completion date: June 30, 2023

Study information

• Verified date: October 2023
• Source: Karolinska Institutet
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

An observational web-based survey on therapist adherence to evidence-based cognitive-behavioral therapy (CBT) in the perspective of their patients with depression or anxiety disorders in psychiatric outpatient care in Stockholm, Sweden. Following completion of CBT, participants respond to questions including their age, gender, education, whether they have improved, whether they considered treatment helpful, and an instrument measuring therapist adherence to CBT procedures (e.g., setting agenda, follow up on home assignments) and CBT techniques (e.g., exposure, cognitive restructuring). The purpose of the study is to contribute to quality assurance of CBT in Stockholm Health Care Services.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 106
• Est. completion date: June 30, 2023
• Est. primary completion date: June 30, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• A primary diagnosis of major depressive disorder, social anxiety disorder, panic disorder, agoraphobia, generalized anxiety disorder, obsessive-compulsive disorder, post-traumatic stress disorder, or illness anxiety disorder
• 18 years of age or older
• Just completed individual cognitive-behavioral therapy in psychiatric outpatient care in Stockholm, Sweden

Exclusion Criteria:

• None

Related Conditions & MeSH terms

• Anxiety Disorders
• Depression

Intervention

Behavioral:
• Cognitive-behavioral therapy
Cognitive-behavioral therapy including both behavioral and cognitive interventions.

Locations

Country	Name	City	State
Sweden	WeMind Psykiatri AB	Stockholm

Sponsors (1)

Lead Sponsor	Collaborator
Karolinska Institutet

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Adherence to Cognitive-Behavioral Therapy Scale - Patient Version	Patients rate the degree to which therapists adhere to evidence-based cognitive-behavioral therapy procedures and techniques on a Likert-type scale from 0 (Not at all) to 4 (To a very high degree)	Up to 20 weeks